Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets AI-powered, MRI-guided, incision-free therapies for the ...
PSA clearance after BPE surgery follows a rapid, predictable pattern. Learn how TURP and OSP impact PSA levels and clinical decisions. Read more.
Joseph J. Busch, Jr., M.D. , a board-certified radiologist and Founder of the Busch Center in Alpharetta, GA, will give a presentation titled "Robotic Assisted MRI-Guided Transurethral Ultrasound ...
PROCEPT BioRobotics trades at 2.9x forward EV/2026E revenue, a deep discount to peers, despite 27-33% guided revenue growth. Learn why PRCT stock is a buy.
If urinary symptoms are affecting you, consult a urologist to explore advanced, minimally invasive treatments like Prostatic Urethral Lift (UroLift). Today's BPH treatments are designed to relieve ...
World’s first robotic Prostatic Artery Embolization (PAE) for Benign Prostatic Hyperplasia (BPH) and robotic Y-90 ...
Spire Southampton Hospital has continued its investment in robotic surgery with the addition of the Aquablation therapy treatment for enlarged prostate (BPH).
IRVINE, CA / ACCESS Newswire / March 27, 2026 / Nymox Pharmaceutical Corporation ("Nymox", "The Company") (OTCQB:NYMXF) will be shortly updating the Board of Directors. Patrick Doody has retired from ...
IRVINE, CA / ACCESS Newswire / March 27, 2026 / Nymox Pharmaceutical Corporation ("Nymox", "The Company") (OTCQB:NYMXF) will be shortly updating the Board of Directors. Patrick Doody has retired from ...
HistoSonics reported the successful treatment of the first patients in WOLVERINE, a new trial evaluating the Edison ...
Bleeding during urologic surgery can lead to transfusions and major complications. The POISE-3 tested prophylaxis in at-risk ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results